Author: Mink van der Molen, Dieuwke R.; Bargon, Claudia A.; Batenburg, Marilot C. T.; Gal, Roxanne; Young-Afat, Danny A.; van Stam, Lilianne E.; van Dam, Iris E.; van der Leij, Femke; Baas, Inge O.; Ernst, Miranda F.; Maarse, Wiesje; Vermulst, Nieke; Schoenmaeckers, Ernst J. P.; van Dalen, Thijs; Bijlsma, Rhodé M.; Doeksen, Annemiek; Verkooijen, Helena M.
Title: (Ex-)breast cancer patients with (pre-existing) symptoms of anxiety and/or depression experience higher barriers to contact health care providers during the COVID-19 pandemic Cord-id: n5lb2pbq Document date: 2021_2_18
ID: n5lb2pbq
Snippet: PURPOSE: To identify factors associated with (perceived) access to health care among (ex-)breast cancer patients during the COVID-19 pandemic. METHODS: Cross-sectional study within a large prospective, multicenter cohort of (ex-)breast cancer patients, i.e., UMBRELLA. All participants enrolled in the UMBRELLA cohort between October 2013 and April 2020 were sent a COVID-19-specific survey, including the Hospital Anxiety and Depression Scale (HADS) questionnaire. RESULTS: In total, 1051 (66.0%) pa
Document: PURPOSE: To identify factors associated with (perceived) access to health care among (ex-)breast cancer patients during the COVID-19 pandemic. METHODS: Cross-sectional study within a large prospective, multicenter cohort of (ex-)breast cancer patients, i.e., UMBRELLA. All participants enrolled in the UMBRELLA cohort between October 2013 and April 2020 were sent a COVID-19-specific survey, including the Hospital Anxiety and Depression Scale (HADS) questionnaire. RESULTS: In total, 1051 (66.0%) participants completed the survey. During COVID-19, 284 (27.0%) participants reported clinically relevant increased levels of anxiety and/or depression, i.e., total HADS score ≥ 12. Participants with anxiety and/or depression reported statistically significant higher barriers to contact their general practitioner (47.5% vs. 25.0%, resp.) and breast cancer physicians (26.8% vs. 11.2%, resp.) compared to participants without these symptoms. In addition, a higher proportion of participants with anxiety and/or depression reported that their current treatment or (after)care was affected by COVID-19 compared to those without these symptoms (32.7% vs. 20.5%, resp.). Factors independently associated with symptoms of anxiety and/or depression during COVID-19 were pre-existent anxiety (OR 6.1, 95% CI 4.1–9.2) or depression (OR 6.0, 95% CI 3.5–10.2). CONCLUSION: During the COVID-19 pandemic, (ex-)breast cancer patients with symptoms of anxiety and/or depression experience higher barriers to contact health care providers. Also, they more often report that their health care was affected by COVID-19. Risk factors for anxiety and/or depression during COVID-19 are pre-existent symptoms of anxiety or depression. Extra attention—including mental health support—is needed for this group.
Search related documents:
Co phrase search for related documents- active participant and logistic regression analysis: 1, 2
- active treatment and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active treatment and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- active treatment and lymph node: 1
- adequate mental health support and logistic regression: 1, 2
- adequate mental health support provide and logistic regression: 1
- adjuvant radiation therapy and logistic regression: 1
- adjuvant radiation therapy and lymph node: 1, 2
- adjuvant radiation therapy and lymph node dissection: 1
- logistic regression analysis and lymph node: 1, 2, 3, 4, 5, 6, 7
- logistic regression analysis and lymph node dissection: 1
- logistic regression and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- logistic regression and lymph node dissection: 1
Co phrase search for related documents, hyperlinks ordered by date